MARKET

CERS

CERS

Cerus
NASDAQ
1.895
+0.055
+2.99%
Opening 10:23 03/26 EDT
OPEN
1.810
PREV CLOSE
1.840
HIGH
1.908
LOW
1.810
VOLUME
134.51K
TURNOVER
--
52 WEEK HIGH
2.955
52 WEEK LOW
1.120
MARKET CAP
364.17M
P/E (TTM)
-23.1098
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CERS last week (0316-0320)?
Weekly Report · 3d ago
Cerus (CERS): Orderly Leadership Transition but Full Valuation Supports Neutral/Hold Rating
TipRanks · 03/17 09:56
Cerus Announces CEO Succession and Executive Compensation Changes
TipRanks · 03/16 21:54
Cerus names Vivek Jayaraman as CEO
TipRanks · 03/16 20:12
*Cerus CEO William 'Obi' Greenman to Become Executive Chmn July 1
Dow Jones · 03/16 20:11
Cerus names Vivek Jayaraman CEO as Obi Greenman becomes executive chairman
Reuters · 03/16 20:05
CERUS CORP - WILLIAM 'OBI' GREENMAN TO BECOME EXECUTIVE CHAIRMAN OF CERUS
Reuters · 03/16 20:05
*Cerus Appoints Vivek Jayaraman As President And Chief Executive Officer >CERS
Dow Jones · 03/16 20:05
More
About CERS
Cerus Corporation is a biomedical products company. The Company is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on its proprietary technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives: platelets, plasma, red blood cells and to produce INTERCEPT Fibrinogen Complex (IFC), and pathogen reduced plasma, cryoprecipitate reduced. The INTERCEPT Blood System for Cryoprecipitation uses its plasma system to produce IFC for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. In addition, the INTERCEPT Blood System for Cryoprecipitation is used to produce pathogen reduced plasma, cryoprecipitate reduced.

Webull offers Cerus Corp stock information, including NASDAQ: CERS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CERS stock methods without spending real money on the virtual paper trading platform.